4 min read
Critical Endpoints in Preclinical Pain Studies: Behavioral, Biomarker, and Electrophysiology Assessments
Developing effective therapeutics for pain requires selecting endpoints that accurately reflect the biological,...
Insights on increasing the translational value of your preclinical development program.
Dec 5, 2025by MD Biosciences
Developing effective therapeutics for pain requires selecting endpoints that accurately reflect the biological,...
Nov 17, 2025by MD Biosciences
At this year’s Society for Neuroscience (SfN) meeting, our team presented a poster highlighting the advantages of using...
Oct 15, 2025by MD Biosciences
At the forefront of translational large-animal research, our team has developed clinically relevant pig models to study...
Sep 15, 2025by MD Biosciences
MD Biosciences has signed the Marseille Declaration, the first joint pharmaceutical industry statement on animal...
Sep 11, 2025by MD Biosciences
We had the opportunity to present at NeuPSIG 2025 in Berlin, sharing our latest findings in neuropathic pain research....